SUBSCRIBE
SUBSCRIBE

Kansas

PRESS RELEASES
Drug Development
Cingulate Successfully Manufactures Clinical Supply – Initiation of Pediatric Phase 3 Studies to Commence in July and August
June 29, 2023
 · 
6 min read
BioMidwest
Cingulate to Participate in the Healthcare Virtual Conference Part II Presented by Maxim Group and Hosted by M-Vest
June 14, 2023
 · 
2 min read
Drug Development
Cingulate Completes Phase 3 Adult Trial of CTx-1301 (dexmethylphenidate) for ADHD
June 8, 2023
 · 
9 min read
BioMidwest
Cingulate to Present at 13th Annual LD Micro Invitational
May 25, 2023
 · 
1 min read
BioMidwest
FlowMetric -[a KCAS Company], Announces Collaboration with Cytek™Biosciences on Implementation of Next Generation Flow Cytometry Technology
May 24, 2023
 · 
4 min read
BioMidwest
Cingulate, Indegene to Participate in Benzinga All Live Access Event
May 12, 2023
 · 
2 min read
Business
Cingulate Inc. Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
May 10, 2023
 · 
11 min read
BioMidwest
Cingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMO
May 3, 2023
 · 
9 min read
Drug Development
Cingulate Completes First Cohort of Phase 3 Adult Onset and Duration Trial of CTx-1301 (dexmethylphenidate) for ADHD
April 4, 2023
 · 
9 min read
Business
Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301
March 13, 2023
 · 
9 min read
Business
Cingulate Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
March 10, 2023
 · 
10 min read
Cingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset CTx-1301 for ADHD
February 23, 2023
 · 
8 min read
Drug Development
Dr. Vince Clinical Research Announces Dosing of Aclaris Therapeutics’ Phase I MAD Study of ATI-2138
January 11, 2023
 · 
2 min read
Drug Development
Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD
January 4, 2023
 · 
10 min read
Garmin Health hits key milestone with completion of 500th research study
October 20, 2022
 · 
4 min read
Policy
See a more complete picture of your health with Index BPM, an FDA-cleared smart blood pressure monitor from Garmin
September 20, 2022
 · 
4 min read
BioMidwest
ELIAS Animal Health Research Demonstrates Cancer-Killing Capabilities of Its Activated T Cell Immunotherapy
August 10, 2022
 · 
2 min read
BioMidwest
New Nonprofit Foundation Makes a Huge Impact on Rare Cancer
July 11, 2022
 · 
2 min read
Business
ELIAS Animal Health Announces Addition of Sales, Marketing & Business Development Leader and Expansion of Scientific Advisory Board
November 23, 2021
 · 
3 min read
Biotech Beach
Genelux Announces Exclusive Out-Licensing Agreement with ELIAS Animal Health for V-VET1, a Proprietary Oncolytic Vaccinia Virus Treatment for Pets with Various Cancers
November 18, 2021
 · 
3 min read
Load More